Skip to main content
New: Manufacturing Quotes — source from manufacturers in 35 countries.Start a Project
GH
United States

FDA Registration & Clearance

US market authorization for medical devices via the FDA's 510(k), De Novo, or PMA pathways.

To verifyUpdated Jun 25, 2026·Issued by U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health
Medical Devices (Class I–III)In Vitro DiagnosticsSoftware as a Medical Device

Overview

What FDA 510(k) / PMA is and why it matters

The U.S. FDA regulates medical devices through a risk-based classification system (Class I, II, III). Most Class II devices reach market via a 510(k) premarket notification demonstrating substantial equivalence to an existing predicate device; novel devices without a predicate may use the De Novo pathway; higher-risk Class III devices generally require a Premarket Approval (PMA) supported by clinical data.

Requirements

What you'll need

  • Device classification (Class I, II, III)
  • FDA establishment registration and device listing
  • 510(k) premarket notification for most Class II devices
  • De Novo pathway for novel low-to-moderate-risk devices with no predicate
  • PMA with clinical data for Class III devices
  • Quality System Regulation / QMSR (21 CFR 820) compliance
  • Labeling per 21 CFR 801
  • Unique Device Identification (UDI) compliance

Typical timeline

336 months

510(k) submissions typically take 3–9 months from filing (excluding pre-submission preparation); PMA pathways with clinical trials can take 1–3 years.

Estimated cost

$10k$500k

510(k) submissions (excluding testing) often run $10k–75k in consulting and FDA fees; PMA pathways with full clinical trials can reach into the millions.

Timelines and costs above are typical ranges illustrating general market patterns, not a quote or regulatory conclusion for your specific product. Actual figures depend on device classification, target country, and applicant readiness — professional review is required before relying on this for a business decision.

Where this applies

Applicable countries

United States

FAQ

Frequently asked questions

What's the difference between 510(k) and PMA?+

510(k) demonstrates a new device is substantially equivalent to one already legally marketed; PMA requires independent clinical evidence of safety and effectiveness and applies mainly to Class III devices.

Do I need a US-based agent?+

Foreign establishments must designate a US Agent for FDA correspondence, though this differs from an EU-style Authorized Representative.

Reviewed launch planning

Ready to start your FDA 510(k) / PMA project?

GHMAP structures your certification path, evidence gaps, and next actions — then connects you with a qualified consultant if you need one.

Professional review remains part of the workflow.